Immune‐based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2– breast cancer
Saved in:
| Main Authors: | Eudald Felip, Edurne Garcia‐Vidal, Sara Cabrero‐de las Heras, Adrià Bernat‐Peguera, Beatriz Cirauqui, Milana Bergamino, Vanesa Quiroga, Iris Teruel, Angelica Ferrando‐Díez, Anna Pous, Assumpció Lopez‐Paradís, Laia Boronat, Marga Romeo, Ricard Mesía, Pedro Luis Fernandez, Bonaventura Clotet, Eva Riveira‐Muñoz, Anna Martínez‐Cardús, Ester Ballana, Mireia Margelí |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.70426 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A translational journey into resistance: decoding the role of NF1 in CDK4/6-inhibitor failure
by: Francesco Schettini, et al.
Published: (2025-08-01) -
X Congrés Internacional Internet, Dret i Política (IDP 2014): una dècada de transformacions
by: Miquel Peguera
Published: (2014-06-01) -
Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01) -
Experience Embedding a Compact eNose in an Indoor Mobile Delivery Robot for the Early Detection of Gas Leaks
by: Ricard Bitriá, et al.
Published: (2025-03-01) -
Interactions between gut microbiota, plasma metabolome and brain function in the setting of a HIV cure trial
by: Alessandra Borgognone, et al.
Published: (2025-08-01)